1.251 - 1.275 of 57.491
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 400,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,22x
- Analysis
- Novo Nordisk Call 370,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,07x
- Analysis
- Novo Nordisk Call 350,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,95x
- Analysis
- Novo Nordisk Call 300,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,66x
- Analysis
- Moderna Call 29,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 1,94x
- Analysis
- Novo Nordisk Call 380,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,16x
- Analysis
- Moderna Call 31,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,00x
- Analysis
- Novo Nordisk Call 320,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,75x
- Analysis
- Moderna Call 27,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 1,79x
- Analysis
- Novo Nordisk Call 290,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,60x
- Analysis
- Novo Nordisk Call 280,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,53x
- Analysis
- Novo Nordisk Call 360,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,77x
- Analysis
- Novo Nordisk Call 360,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,03x
- Analysis
- Novo Nordisk Call 310,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,73x
- Analysis
- Novo Nordisk Call 320,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,61x
- Analysis
- Novo Nordisk Call 270,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,44x
- Analysis
- Novo Nordisk Call 370,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,43x
- Analysis
- Novo Nordisk Call 260,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,42x
- Analysis
- Novo Nordisk Call 400,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,64x
- Analysis
- Novo Nordisk Call 250,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,33x
- Analysis
- Novo Nordisk Call 390,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,59x
- Analysis
- Novo Nordisk Call 320,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,08x
- Analysis
- Novo Nordisk Call 240,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,27x
- Analysis
- Oracle Call 215,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,69x
- Analysis
- Oracle Call 210,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,67x
- Analysis